NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Suez Jam, Jobless Claims, AstraZeneca Update - What's up in Markets

Published 25/03/2021, 11:34
© Reuters.
BAC
-
HMb
-
PFE
-
LCO
-
ESZ24
-
CL
-
1YMZ24
-
NQZ24
-
NKE
-
AZN
-
BTC/USD
-
MRNA
-

By Geoffrey Smith 

Investing.com -- More and more ships are backed up waiting to get into the Suez Canal, which may remain blocked until Sunday. The EU and U.K. dial down their vaccine war, ahead of a summit President Joe Biden wll Zoom in to call for a united front against China, where a government media-led backlash against Nike (NYSE:NKE) and H&M (ST:HMb) is in progress after the companies said they would cut ties with cotton suppliers in Xinjiang over claims of forced labor. AstraZeneca (NASDAQ:AZN) revises down its assessment of the efficacy of its Covid-19 drug - not by much, but enough to create some more head-scratching. And jobless claims data are expected to show  the downward trend in unemployment reasserting itself. Here's what you need to know in financial markets on Thursday, March 25th.

1. Suez still blocked

The Suez Canal, one of the most important arteries for global trade, remained blocked for a third day after a massive container ship jammed against its walls in heavy winds on Tuesday.

Bloomberg reported that an elite salvage squad is due to arrive on site later Thursday to add its efforts to those of tugboats and diggers which have so far failed to extract the ship, which is longer than Paris’s Eiffel Tower is tall. Dutch state TV quoted the head of that salvage company as saying that it might "take weeks" to unblock the canal.

The blockage has left over 100 ships stranded while waiting for entrance to the Canal, a disruption that promises to be reflected in commodity prices and trade flows for at least a month. The Canal acts not only as a major conduit of crude oil from the Persian Gulf to Europe and the U.S. east coast, but also for Russian oil being shipped to Asia. 

Crude futures were down 1.7% at $60.17 a barrel, while Brent crude was down 1.3% at $63.55 a barrel.

2. Europe, U.K. dial down vaccine war; AstraZeneca revises drug data

The U.K. and EU signaled a truce in their fight over vaccines, pledging to work together in a joint statement released ahead of an EU summit later in the day. The summit will also be attended, remotely, by U.S. President Joe Biden.

Overnight, AstraZeneca updated its U.S. trial results to show a slightly lower efficacy rate for its Covid-19 vaccine. It now says the drug is 76% effective in stopping the virus, and repeated that it is 100% successful in preventing death and hospitalization.  

The discrepancy with the initial results nonetheless sheds an unwelcome light on AZ’s internal processes, adding to previous confusion over its initial test results in Europe.  The AZ virus is a vital part of the global vaccination campaign, being substantially cheaper than those offered by Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA). That’s important because the two worst outbreaks in the world at the present are raging in India and Brazil. 

 3 Stocks set to open higher; jobless claims, Fed speakers eyed

U.S. stocks are set to open modestly higher after their declines on Wednesday, with attention likely to be focused on the weekly jobless claims report at 8:30 AM ET (1230 GMT).

By 6:30 AM ET (1030 GMT), Dow Jones Futures were up 75 points, or 0.2%, while S&P 500 futures were up 0.3% and Nasdaq 100 futures were up 0.5%.

Initial claims are expected to have fallen to 730,000 from 770,000 the previous week, but arguably the more important number will be, as always, the total number of people on unemployment-related benefits. The final reading of fourth-quarter GDP is also due at the same time.

There will be speeches from Federal Reserve members, John Williams, Richard Clarida, Charles Evans, Mary Daly and Raphael Bostic in the course of the day.

4. Emerging central banks ponder rising inflation; Bitcoin's slide continues 

It’s another big day for emerging market central banks, with South Africa and Mexico both due to announce their latest monetary policy decisions. Inflationary pressures forced Turkey, Russia and Brazil into raising interest rates last week, and while analysts don’t expect a hike at either meeting, the Mexican central bank in particular is expected to move to more hawkish guidance.

Overnight, Switzerland left its monetary policy unchanged but toned down its talk about possibly intervening to cap the franc’s rise.

In the digital currency space, Bitcoin continued to slide against a backdrop of negative commentary about Tesla’s embrace of it. Bank of America (NYSE:BAC) analysts issued a note highlighting the currency’s carbon footprint, which is at odds with Tesla’s stated goal of reducing carbon emissions. At a conference held by the Bank for International Settlements, former ECB board member Benoit Coeure repeated that Bitcoin has “failed” to establish itself as a genuine currency.

5. Nike, H&M feel Chinese backlash after Xinjiang cotton boycott

Stocks in focus later may include Nike, which is facing a backlash in China after cutting ties with cotton suppliers in the province of Xinjiang. Swedish fashion chain H&M is having the same problem.

The companies made their moves after the U.S., EU and U.K. all imposed sanctions on Chinese officials in relation to allegations of human rights violations in Xinjiang, where the U.S. says China is conducting a genocide of its Muslim Uighur minority. China has angrily responded to what it sees as interference in its domestic affairs.

Biden’s participation at the EU summit later is intended to reflect a more united stance by the West vis-à-vis China.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.